Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 122 entries
Sorted by: Best Match Show Resources per page
Erratum: Intrathoracic kidney with left-sided Bochdalek hernia in a woman with bacteremic acute pyelonephritis due to Escherichia coli.

The Korean journal of internal medicine

Noh YS, Kim Y, Seo Y, Wie SH, Chang UI.
PMID: 25995678
Korean J Intern Med. 2015 May;30(3):421. doi: 10.3904/kjim.2015.30.3.421.

No abstract available.

Cite
Noh YS, Kim Y, Seo Y, et al. Erratum: Intrathoracic kidney with left-sided Bochdalek hernia in a woman with bacteremic acute pyelonephritis due to Escherichia coli. Korean J Intern Med. 2015;30(3):421doi: 10.3904/kjim.2015.30.3.421.
Noh, Y. S., Kim, Y., Seo, Y., Wie, S. H., & Chang, U. I. (2015). Erratum: Intrathoracic kidney with left-sided Bochdalek hernia in a woman with bacteremic acute pyelonephritis due to Escherichia coli. The Korean journal of internal medicine, 30(3), 421. https://doi.org/10.3904/kjim.2015.30.3.421
Noh, Yong-sun, et al. "Erratum: Intrathoracic kidney with left-sided Bochdalek hernia in a woman with bacteremic acute pyelonephritis due to Escherichia coli." The Korean journal of internal medicine vol. 30,3 (2015): 421. doi: https://doi.org/10.3904/kjim.2015.30.3.421
Noh YS, Kim Y, Seo Y, Wie SH, Chang UI. Erratum: Intrathoracic kidney with left-sided Bochdalek hernia in a woman with bacteremic acute pyelonephritis due to Escherichia coli. Korean J Intern Med. 2015 May;30(3):421. doi: 10.3904/kjim.2015.30.3.421. PMID: 25995678; PMCID: PMC4438302.
Copy Download .nbib Format: NLM
Crohn's disease in Korea: past, present, and future.

The Korean journal of internal medicine

Lee KM, Lee JM.
PMID: 25228829
Korean J Intern Med. 2014 Sep;29(5):558-70. doi: 10.3904/kjim.2014.29.5.558. Epub 2014 Aug 28.

The epidemiology, genetics, and clinical manifestations of Crohn's disease (CD) vary considerably among geographic areas and ethnic groups. Thus, identifying the characteristics of Korean CD is important for establishing management strategies appropriate for Korean patients. Since the mid-2000s, many...

Cite
Lee KM, Lee JM. Crohn's disease in Korea: past, present, and future. Korean J Intern Med. 2014;29(5):558-70doi: 10.3904/kjim.2014.29.5.558.
Lee, K. M., & Lee, J. M. (2014). Crohn's disease in Korea: past, present, and future. The Korean journal of internal medicine, 29(5), 558-70. https://doi.org/10.3904/kjim.2014.29.5.558
Lee, Kang-Moon, and Lee, Ji Min. "Crohn's disease in Korea: past, present, and future." The Korean journal of internal medicine vol. 29,5 (2014): 558-70. doi: https://doi.org/10.3904/kjim.2014.29.5.558
Lee KM, Lee JM. Crohn's disease in Korea: past, present, and future. Korean J Intern Med. 2014 Sep;29(5):558-70. doi: 10.3904/kjim.2014.29.5.558. Epub 2014 Aug 28. PMID: 25228829; PMCID: PMC4164717.
Copy Download .nbib Format: NLM
Does nondiabetic renal disease exacerbate diabetic nephropathy in patients with type 2 diabetes?.

The Korean journal of internal medicine

Park CW.
PMID: 24009449
Korean J Intern Med. 2013 Sep;28(5):544-6. doi: 10.3904/kjim.2013.28.5.544. Epub 2013 Aug 14.

No abstract available.

Cite
Park CW. Does nondiabetic renal disease exacerbate diabetic nephropathy in patients with type 2 diabetes?. Korean J Intern Med. 2013;28(5):544-6doi: 10.3904/kjim.2013.28.5.544.
Park, C. W. (2013). Does nondiabetic renal disease exacerbate diabetic nephropathy in patients with type 2 diabetes?. The Korean journal of internal medicine, 28(5), 544-6. https://doi.org/10.3904/kjim.2013.28.5.544
Park, Cheol Whee. "Does nondiabetic renal disease exacerbate diabetic nephropathy in patients with type 2 diabetes?." The Korean journal of internal medicine vol. 28,5 (2013): 544-6. doi: https://doi.org/10.3904/kjim.2013.28.5.544
Park CW. Does nondiabetic renal disease exacerbate diabetic nephropathy in patients with type 2 diabetes?. Korean J Intern Med. 2013 Sep;28(5):544-6. doi: 10.3904/kjim.2013.28.5.544. Epub 2013 Aug 14. PMID: 24009449; PMCID: PMC3759759.
Copy Download .nbib Format: NLM
Comparison of antiplatelet treatment in patients with clopidogrel nonresponders with or without carriage of CYP2C19 polymorphism.

The Korean journal of internal medicine

Ko YM, Kim JK, Kim JH, Park SH, Choi RK.
PMID: 29843492
Korean J Intern Med. 2018 May 31; doi: 10.3904/kjim.2017.363. Epub 2018 May 31.

BACKGROUND/AIMS: Several interventions exist for overcoming high platelet reactivity (HPR) on clopidogrel therapy. The goal of this study was to identify strategies that improve inhibition of platelet reactivity in clopidogrel nonresponders with or without loss of function CYP2C19 genotypes,...

Cite
Ko YM, Kim JK, Kim JH, et al. Comparison of antiplatelet treatment in patients with clopidogrel nonresponders with or without carriage of CYP2C19 polymorphism. Korean J Intern Med. 2018;doi: 10.3904/kjim.2017.363.
Ko, Y. M., Kim, J. K., Kim, J. H., Park, S. H., & Choi, R. K. (2018). Comparison of antiplatelet treatment in patients with clopidogrel nonresponders with or without carriage of CYP2C19 polymorphism. The Korean journal of internal medicine, . https://doi.org/10.3904/kjim.2017.363
Ko, Yun Myoung, et al. "Comparison of antiplatelet treatment in patients with clopidogrel nonresponders with or without carriage of CYP2C19 polymorphism." The Korean journal of internal medicine vol. (2018). doi: https://doi.org/10.3904/kjim.2017.363
Ko YM, Kim JK, Kim JH, Park SH, Choi RK. Comparison of antiplatelet treatment in patients with clopidogrel nonresponders with or without carriage of CYP2C19 polymorphism. Korean J Intern Med. 2018 May 31; doi: 10.3904/kjim.2017.363. Epub 2018 May 31. PMID: 29843492.
Copy Download .nbib Format: NLM
Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot study.

The Korean journal of internal medicine

Stepanova N, Driianska V, Korol L, Snisar L, Lebed L.
PMID: 34167288
Korean J Intern Med. 2021 Jun 25; doi: 10.3904/kjim.2020.561. Epub 2021 Jun 25.

BACKGROUND/AIMS: It was hypothesized that oxalate might be strongly involved in atherogenesis and the inflammatory pathway that could result in an increased risk of cardiovascular disease (CVD) in end-stage renal disease (ESRD) patients. Therefore, this study aimed to address...

Cite
Stepanova N, Driianska V, Korol L, et al. Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot study. Korean J Intern Med. 2021;doi: 10.3904/kjim.2020.561.
Stepanova, N., Driianska, V., Korol, L., Snisar, L., & Lebed, L. (2021). Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot study. The Korean journal of internal medicine, . https://doi.org/10.3904/kjim.2020.561
Stepanova, Natalia, et al. "Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot study." The Korean journal of internal medicine vol. (2021). doi: https://doi.org/10.3904/kjim.2020.561
Stepanova N, Driianska V, Korol L, Snisar L, Lebed L. Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot study. Korean J Intern Med. 2021 Jun 25; doi: 10.3904/kjim.2020.561. Epub 2021 Jun 25. PMID: 34167288.
Copy Download .nbib Format: NLM
Burden of comorbidities and medication use in childbearing women with rheumatic diseases: a nationwide population-based study.

The Korean journal of internal medicine

Chung MK, Lee CH, Park JS, Lim H, Lee J.
PMID: 34233434
Korean J Intern Med. 2021 Jul 09; doi: 10.3904/kjim.2021.089. Epub 2021 Jul 09.

BACKGROUND/AIMS: We aimed to estimate the prevalence of comorbidities and medication use in Korean women with rheumatic diseases (RDs) during their childbearing years.METHODS: We included women aged 20 to 44 years with seropositive rheumatoid arthritis (RA), systemic lupus erythematosus...

Cite
Chung MK, Lee CH, Park JS, et al. Burden of comorbidities and medication use in childbearing women with rheumatic diseases: a nationwide population-based study. Korean J Intern Med. 2021;doi: 10.3904/kjim.2021.089.
Chung, M. K., Lee, C. H., Park, J. S., Lim, H., & Lee, J. (2021). Burden of comorbidities and medication use in childbearing women with rheumatic diseases: a nationwide population-based study. The Korean journal of internal medicine, . https://doi.org/10.3904/kjim.2021.089
Chung, Min Kyung, et al. "Burden of comorbidities and medication use in childbearing women with rheumatic diseases: a nationwide population-based study." The Korean journal of internal medicine vol. (2021). doi: https://doi.org/10.3904/kjim.2021.089
Chung MK, Lee CH, Park JS, Lim H, Lee J. Burden of comorbidities and medication use in childbearing women with rheumatic diseases: a nationwide population-based study. Korean J Intern Med. 2021 Jul 09; doi: 10.3904/kjim.2021.089. Epub 2021 Jul 09. PMID: 34233434.
Copy Download .nbib Format: NLM
Korean physician prescription patterns for home oxygen therapy in chronic obstructive pulmonary disease patients.

The Korean journal of internal medicine

Kim Y, Kim HI, Park JY, Hong JY, Kim JH, Min KH, Rhee CK, Park S, Lee CY, Lim SY, Jang SH, Hwang YI.
PMID: 34412177
Korean J Intern Med. 2022 Jan;37(1):119-126. doi: 10.3904/kjim.2020.470. Epub 2021 Aug 20.

BACKGROUND/AIMS: Hypoxemia in chronic obstructive pulmonary disease (COPD) leads to reduced ability to exercise, decreased quality of life, and, eventually, increased mortality. Home oxygen therapy in patients with severe COPD reduces distress symptoms and mortality rates. However, there have...

Cite
Kim Y, Kim HI, Park JY, et al. Korean physician prescription patterns for home oxygen therapy in chronic obstructive pulmonary disease patients. Korean J Intern Med. 2021;37(1):119-126doi: 10.3904/kjim.2020.470.
Kim, Y., Kim, H. I., Park, J. Y., Hong, J. Y., Kim, J. H., Min, K. H., Rhee, C. K., Park, S., Lee, C. Y., Lim, S. Y., Jang, S. H., & Hwang, Y. I. (2022). Korean physician prescription patterns for home oxygen therapy in chronic obstructive pulmonary disease patients. The Korean journal of internal medicine, 37(1), 119-126. https://doi.org/10.3904/kjim.2020.470
Kim, Youlim, et al. "Korean physician prescription patterns for home oxygen therapy in chronic obstructive pulmonary disease patients." The Korean journal of internal medicine vol. 37,1 (2022): 119-126. doi: https://doi.org/10.3904/kjim.2020.470
Kim Y, Kim HI, Park JY, Hong JY, Kim JH, Min KH, Rhee CK, Park S, Lee CY, Lim SY, Jang SH, Hwang YI. Korean physician prescription patterns for home oxygen therapy in chronic obstructive pulmonary disease patients. Korean J Intern Med. 2022 Jan;37(1):119-126. doi: 10.3904/kjim.2020.470. Epub 2021 Aug 20. PMID: 34412177.
Copy Download .nbib Format: NLM
Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center.

The Korean journal of internal medicine

Park Y, Kim D, Yang JH, Cho YH, Choi JO, Jeon ES.
PMID: 34871480
Korean J Intern Med. 2021 Dec 07; doi: 10.3904/kjim.2021.088. Epub 2021 Dec 07.

BACKGROUND/AIMS: The continuous flow left ventricular assist device (cf-LVAD) has improved the survival of chronic end-stage heart failure (HF) patients. Here we describe our clinical experience of the initial 50 LVAD patients from a single center.METHODS: A total of...

Cite
Park Y, Kim D, Yang JH, et al. Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center. Korean J Intern Med. 2021;doi: 10.3904/kjim.2021.088.
Park, Y., Kim, D., Yang, J. H., Cho, Y. H., Choi, J. O., & Jeon, E. S. (2021). Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center. The Korean journal of internal medicine, . https://doi.org/10.3904/kjim.2021.088
Park, Yoonjee, et al. "Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center." The Korean journal of internal medicine vol. (2021). doi: https://doi.org/10.3904/kjim.2021.088
Park Y, Kim D, Yang JH, Cho YH, Choi JO, Jeon ES. Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center. Korean J Intern Med. 2021 Dec 07; doi: 10.3904/kjim.2021.088. Epub 2021 Dec 07. PMID: 34871480.
Copy Download .nbib Format: NLM
Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01).

The Korean journal of internal medicine

Kang EJ, Lee YG, Keam B, Choi JH, Kim JS, Park KU, Lee KE, Kim HJ, Lee KW, Kim MK, Ahn HK, Shin SH, Lee JB, Kwon JH, Kim HR, Kim SB, Yun HJ.
PMID: 34929077
Korean J Intern Med. 2022 Jan;37(1):190-200. doi: 10.3904/kjim.2020.636. Epub 2021 Dec 21.

BACKGROUND/AIMS: Treatment decisions for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) are complicated, and multi-modal treatments are usually indicated. However, it is challenging for older patients to complete treatments. Thus, we investigated disease characteristics, real-world treatment, and...

Cite
Kang EJ, Lee YG, Keam B, et al. Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01). Korean J Intern Med. 2021;37(1):190-200doi: 10.3904/kjim.2020.636.
Kang, E. J., Lee, Y. G., Keam, B., Choi, J. H., Kim, J. S., Park, K. U., Lee, K. E., Kim, H. J., Lee, K. W., Kim, M. K., Ahn, H. K., Shin, S. H., Lee, J. B., Kwon, J. H., Kim, H. R., Kim, S. B., & Yun, H. J. (2022). Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01). The Korean journal of internal medicine, 37(1), 190-200. https://doi.org/10.3904/kjim.2020.636
Kang, Eun Joo, et al. "Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01)." The Korean journal of internal medicine vol. 37,1 (2022): 190-200. doi: https://doi.org/10.3904/kjim.2020.636
Kang EJ, Lee YG, Keam B, Choi JH, Kim JS, Park KU, Lee KE, Kim HJ, Lee KW, Kim MK, Ahn HK, Shin SH, Lee JB, Kwon JH, Kim HR, Kim SB, Yun HJ. Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01). Korean J Intern Med. 2022 Jan;37(1):190-200. doi: 10.3904/kjim.2020.636. Epub 2021 Dec 21. PMID: 34929077.
Copy Download .nbib Format: NLM
The optimal anti-phospholipase A2 receptor cutoff for the diagnosis of idiopathic membranous nephropathy: a single-center retrospective study.

The Korean journal of internal medicine

Li C, Li P, Guo W, Chen L, Li J, Wang R, Chen B.
PMID: 32972118
Korean J Intern Med. 2022 Jan;37(1):154-166. doi: 10.3904/kjim.2020.366. Epub 2021 Jul 22.

BACKGROUND/AIMS: Anti-phospholipase A2 receptor (PLA2R) autoantibody is the main biomarker of idiopathic membranous nephropathy (IMN). We aimed to find a new cutoff value of anti-PLA2R for patients with IMN and to explore the relevance between this antibody and baseline...

Cite
Li C, Li P, Guo W, et al. The optimal anti-phospholipase A2 receptor cutoff for the diagnosis of idiopathic membranous nephropathy: a single-center retrospective study. Korean J Intern Med. 2021;37(1):154-166doi: 10.3904/kjim.2020.366.
Li, C., Li, P., Guo, W., Chen, L., Li, J., Wang, R., & Chen, B. (2022). The optimal anti-phospholipase A2 receptor cutoff for the diagnosis of idiopathic membranous nephropathy: a single-center retrospective study. The Korean journal of internal medicine, 37(1), 154-166. https://doi.org/10.3904/kjim.2020.366
Li, Chaofan, et al. "The optimal anti-phospholipase A2 receptor cutoff for the diagnosis of idiopathic membranous nephropathy: a single-center retrospective study." The Korean journal of internal medicine vol. 37,1 (2022): 154-166. doi: https://doi.org/10.3904/kjim.2020.366
Li C, Li P, Guo W, Chen L, Li J, Wang R, Chen B. The optimal anti-phospholipase A2 receptor cutoff for the diagnosis of idiopathic membranous nephropathy: a single-center retrospective study. Korean J Intern Med. 2022 Jan;37(1):154-166. doi: 10.3904/kjim.2020.366. Epub 2021 Jul 22. PMID: 32972118.
Copy Download .nbib Format: NLM
Long-term outcomes in ST-elevation myocardial infarction patients treated according to hospital visit time.

The Korean journal of internal medicine

Oh S, Hyun DY, Cho KH, Kim JH, Jeong MH.
PMID: 34781424
Korean J Intern Med. 2021 Nov 16; doi: 10.3904/kjim.2021.204. Epub 2021 Nov 16.

BACKGROUND/AIMS: Rapid percutaneous coronary intervention (PCI) is the cornerstone of treatment for ST-elevation myocardial infarction (STEMI). However, there have been conflicting results regarding the differences in clinical outcomes between on-hours and off-hours presentation in STEMI patients. We aimed to...

Cite
Oh S, Hyun DY, Cho KH, et al. Long-term outcomes in ST-elevation myocardial infarction patients treated according to hospital visit time. Korean J Intern Med. 2021;doi: 10.3904/kjim.2021.204.
Oh, S., Hyun, D. Y., Cho, K. H., Kim, J. H., & Jeong, M. H. (2021). Long-term outcomes in ST-elevation myocardial infarction patients treated according to hospital visit time. The Korean journal of internal medicine, . https://doi.org/10.3904/kjim.2021.204
Oh, Seok, et al. "Long-term outcomes in ST-elevation myocardial infarction patients treated according to hospital visit time." The Korean journal of internal medicine vol. (2021). doi: https://doi.org/10.3904/kjim.2021.204
Oh S, Hyun DY, Cho KH, Kim JH, Jeong MH. Long-term outcomes in ST-elevation myocardial infarction patients treated according to hospital visit time. Korean J Intern Med. 2021 Nov 16; doi: 10.3904/kjim.2021.204. Epub 2021 Nov 16. PMID: 34781424.
Copy Download .nbib Format: NLM
Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease.

The Korean journal of internal medicine

Kim JW, Choe JY, Park SH.
PMID: 34879473
Korean J Intern Med. 2022 Jan;37(1):13-26. doi: 10.3904/kjim.2021.363. Epub 2021 Dec 10.

Metformin is a first-line therapeutic agent for type 2 diabetes. Apart from its glucose-lowering effect, metformin is attracting interest regarding possible therapeutic benefits in various other conditions. As metformin regulates cell metabolism, proliferation, growth, and autophagy, it may also...

Cite
Kim JW, Choe JY, Park SH. Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease. Korean J Intern Med. 2021;37(1):13-26doi: 10.3904/kjim.2021.363.
Kim, J. W., Choe, J. Y., & Park, S. H. (2022). Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease. The Korean journal of internal medicine, 37(1), 13-26. https://doi.org/10.3904/kjim.2021.363
Kim, Ji-Won, et al. "Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease." The Korean journal of internal medicine vol. 37,1 (2022): 13-26. doi: https://doi.org/10.3904/kjim.2021.363
Kim JW, Choe JY, Park SH. Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease. Korean J Intern Med. 2022 Jan;37(1):13-26. doi: 10.3904/kjim.2021.363. Epub 2021 Dec 10. PMID: 34879473.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 122 entries